[1] |
ZHU Xinzhe, LI Hao, XU Huaxiang, LUO Guopei, YU Xianjun.
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2021
[J]. China Oncology, 2022, 32(1): 1-12.
|
[2] |
YANG Shipeng , LIU Ying , WANG Xinyue , YANG Yang , QUAN Jishu , LIN Zhenhua .
Clinical significance of PKLR overexpression in the pancreatic cancer
[J]. China Oncology, 2021, 31(8): 704-713.
|
[3] |
LI Haizhou , ZHANG Yanwei , XU Yingjie , YANG Men , ZHANG Lei , HAN Jingjun .
miR-933 inhibits proliferation, migration and invasion of lung cancer cell lines by regulation of KLF6 gene
[J]. China Oncology, 2021, 31(7): 581-588.
|
[4] |
CAO Dalong, ZHU Wenkai, SHI Guohai, ZHANG Hailiang, WANG Ziliang, YE Dingwei.
The influence of PRUNE2 gene point mutation on proliferation, apoptosis, invasion and migration of prostate cancer DU145 cells
[J]. China Oncology, 2021, 31(6): 441-446.
|
[5] |
HUA Qing, SHEN Xuefang, XU Pingbo .
Effect of KLK8 on apoptosis of colorectal cancer cells by regulating EGF and its mechanism
[J]. China Oncology, 2021, 31(5): 383-389.
|
[6] |
CHEN Guo , HAN Pengli , CHEN Keru , LI Mingchuang , ZHANG Qingsong , CHEN Zheng , DONG Hanhua , QIAN Yuejun , LÜ Jing .
Molecular mechanism of miR-19b-3p regulating apoptosis of medullary thyroid cancer cells by targeting MTUS1
[J]. China Oncology, 2021, 31(5): 390-396.
|
[7] |
TANG Rong, SHI Si, ZHANG Bo, XU Jin, WANG Wei, YU Xianjun.
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020
[J]. China Oncology, 2021, 31(1): 1-10.
|
[8] |
CHEN Shaogeng, HE Rongqi, ZHANG Wanfei, LIN Xianzuan, CHEN Heshan, XU Rongyu.
miR-122-5p inhibits the growth of esophageal cancer cells and transplanted tumors by targeting CREB1
[J]. China Oncology, 2021, 31(1): 35-44.
|
[9] |
OUYANG Xiaochun , ZOU Yeqing , LI Yumei , DING Xiaobing .
ARHGAP4 promotes growth of hepatocellular carcinoma cells by regulating HK2 expression
[J]. China Oncology, 2020, 30(7): 481-487.
|
[10] |
ZHANG Xiaomeng , MA Ningyi , ZHU Hongcheng , AI Dashan , REN Zhigang .
Efficacy and prognostic factors of adjuvant radiotherapy combined with chemotherapy in patients with pancreatic cancer
[J]. China Oncology, 2020, 30(7): 519-524.
|
[11] |
WANG Fang , WANG Xin , LIU Zhe , HUI Lingyun , FENG Ai , LI Na , WANG Yawen .
Inhibition of PDK1 induces apoptosis in CML cells via activation of ASK1/JNK/Bim cascade
[J]. China Oncology, 2020, 30(6): 401-406.
|
[12] |
TONG Ying, YU Yiwen, XIE Suhong, WANG Yanchun, LU Renquan, GUO Lin.
Effects of silent information regulator 4 overexpression or glutamine deprivation on apoptosis and proliferation of clear cell renal cell carcinoma
[J]. China Oncology, 2020, 30(6): 435-440.
|
[13] |
LIU Peng , GONG Yang , LIU Daojiang , ZHANG Xiang , ZHANG Jianan , YANG Gaoliang , FANG Nian .
A study on the expression of PFKFB3 in gastric cancer and its effect on the growth and apoptosis of gastric cancer cells
[J]. China Oncology, 2020, 30(4): 268-274.
|
[14] |
YAN Feihu , ZOU Rui , WANG Yiyao , WANG Fangfang , RAN Haonan , WANG Yan .
Expression of PRMT5 in gastric cancer and its influences on proliferation, apoptosis and migration ability of gastric cancer cells
[J]. China Oncology, 2020, 30(4): 275-283.
|
[15] |
MAO Tiebo, CUI Jiujie, WANG Liwei.
Research progress in pancreatic cancer in 2019 from experimental study to clinical evaluation
[J]. China Oncology, 2020, 30(2): 81-89.
|